Remix Therapeutics
PrivateLast Round
Private Placement
Jun 24, 2026
Est. Valuation
$326M
Total Funding Raised
$183M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Remix Therapeutics is a biotechnology company that develops small molecule therapies designed to reprogram RNA processing to treat diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remix Therapeutics Comparables
Compare Remix Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arrakis Therapeutics | 86% | |
| Skyhawk Therapeutics | 80% | |
| Accent Therapeutics | 80% | |
Remix Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Jun 24, 2026 | ||||
| VC Round | Jan 3, 2024 | ||||
| Series B | May 17, 2022 | ||||
| Series A | Dec 8, 2020 |
Key People
Founding team and executive leadership
Remix Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series A, Private Placement, Series B, Seed, VC Round |
| Surveyor Capital | VC Round, Series B |
| ARCH Venture Partners | Series A, VC Round, Series B |
| The Chernin Group | Series A, Series B, VC Round |
| ARCH Venture Partners | Series A, VC Round, Series B |
| Forge Life Science Partners | Private Placement |
| Foresite Capital | VC Round, Private Placement, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 37% MoM, reaching 4.5K.
- Apr 21, 2026
Results from Phase 1/2 ARIA Trial of REM-422 to be presented at 2026 ASCO Annual Meeting.
Remix Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Remix Therapeutics's valuation, stock price, and market status.